Enhanced by technology, dual-enrollment programs cultivate a skilled workforce while serving underserved communities.

Q1 2025 Management View Peter Greenleaf, President and CEO, highlighted "strong growth in total revenue and net product sales ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross margin; Three of the top 10 U.S. transplant centers expected to participate in clinical trial; Ten globally leading t ...